Trichinosis future or investigational therapies: Difference between revisions

Jump to navigation Jump to search
No edit summary
m (Changes made per Mahshid's request)
 
(6 intermediate revisions by 2 users not shown)
Line 1: Line 1:
__NONTOC__
__NOTOC__
{{Trichinosis}}
{{Trichinosis}}
Please help WikiDoc by adding content here. It's easy!  Click  [[Help:How_to_Edit_a_Page|here]] to learn about editing.
{{CMG}}{{AE}}{{DL}}
 
== Vaccine research ==
*There are currently no vaccines for trichinosis, although experimental mice studies have suggested a possibility
*In one study, microwaved [[Trichinella|''Trichinella'']] larvae were used to immunize mice, which were subsequently infected. Depending on dosage and the frequency of immunization, results ranged from a decreased larval count to complete protection from trichinosis
*Another study, used extracts and excretory-secretory products from first stage larvae to produce an oral vaccine. To prevent the gastric acids from dissolving the antigens before reaching the small intestine, scientists encapsulated the antigens in a microcapsule made of copolymers. This vaccine significantly increased [[CD4+ cell|CD4+ cells]] and increased antigen-specific serum [[IgG]] and [[IgA]], resulting in a [[statistically significant]] reduction in the average number of adult worms in the small intestine of mice. The significance of this approach is that if the [[white blood cells]] in the small intestine have been exposed to [[Trichinella|''Trichinella'']] antigens (through vaccination) then, when an individual gets infected, the immune system will respond to expel the worms from the small intestine fast enough to prevent the female worms from releasing their larvae
*Another study tested a [[DNA vaccine]] on mice which "induced a muscle larvae burden reduction in [[BALB/c]] mice by 29% in response to [[Trichinella spiralis|''T. spiralis'']] infection"
*Researchers trying to develop a vaccine for [[Trichinella|''Trichinella'']] have tried to using either "larval extracts, excretory-secretory antigen, [[DNA vaccine]], or recombinant antigen protein"<ref name="wiki1234">Trichinosis. Wikipedia. https://en.wikipedia.org/wiki/Trichinosis. Accessed on January 22, 2016</ref>


==References==
==References==
Line 7: Line 14:




[[Category:Conditions diagnosed by stool test]]
[[Category:Needs overview]]
[[Category:Infectious disease]]
 
[[Category:Needs content]]
{{WH}}
{{WS}}

Latest revision as of 19:01, 18 September 2017

Trichinosis Microchapters

Home

Patient Information

Overview

Historical perspective

Classification

Pathophysiology

Causes

Differentiating Trichinosis from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Criteria

History and Symptoms

Physical Examination

Laboratory Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Trichinosis future or investigational therapies On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Trichinosis future or investigational therapies

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Trichinosis future or investigational therapies

CDC on Trichinosis future or investigational therapies

Trichinosis future or investigational therapies in the news

Blogs on Trichinosis future or investigational therapies

Directions to Hospitals Treating Trichinosis

Risk calculators and risk factors for Trichinosis future or investigational therapies

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Danitza Lukac

Vaccine research

  • There are currently no vaccines for trichinosis, although experimental mice studies have suggested a possibility
  • In one study, microwaved Trichinella larvae were used to immunize mice, which were subsequently infected. Depending on dosage and the frequency of immunization, results ranged from a decreased larval count to complete protection from trichinosis
  • Another study, used extracts and excretory-secretory products from first stage larvae to produce an oral vaccine. To prevent the gastric acids from dissolving the antigens before reaching the small intestine, scientists encapsulated the antigens in a microcapsule made of copolymers. This vaccine significantly increased CD4+ cells and increased antigen-specific serum IgG and IgA, resulting in a statistically significant reduction in the average number of adult worms in the small intestine of mice. The significance of this approach is that if the white blood cells in the small intestine have been exposed to Trichinella antigens (through vaccination) then, when an individual gets infected, the immune system will respond to expel the worms from the small intestine fast enough to prevent the female worms from releasing their larvae
  • Another study tested a DNA vaccine on mice which "induced a muscle larvae burden reduction in BALB/c mice by 29% in response to T. spiralis infection"
  • Researchers trying to develop a vaccine for Trichinella have tried to using either "larval extracts, excretory-secretory antigen, DNA vaccine, or recombinant antigen protein"[1]

References

  1. Trichinosis. Wikipedia. https://en.wikipedia.org/wiki/Trichinosis. Accessed on January 22, 2016